1-888-210-3553

1-888-210-3553

The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions

Background

Research on the clinical applications of psychedelic-assisted psychotherapy has demonstrated promising early results for treatment of alcohol dependence. Detailed description of the content and methods of psychedelic-assisted psychotherapy, as it is conducted in clinical settings, is scarce.

 

Methods

An open-label pilot (proof-of-concept) study of psilocybin-assisted treatment of alcohol dependence (NCT01534494) was conducted to generate data for a phase 2 RCT (NCT02061293) of a similar treatment in a larger population. The present paper presents a qualitative content analysis of the 17 debriefing sessions conducted in the pilot study, which occurred the day after corresponding psilocybin medication sessions.

 

Results

Participants articulated a series of key phenomena related to change in drinking outcomes and acute subjective effects of psilocybin.

 

Discussion

The data illuminate change processes in patients’ own words during clinical sessions, shedding light on potential therapeutic mechanisms of change and how participants express effects of psilocybin. This study is unique in analyzing actual clinical sessions, as opposed to interviews of patients conducted separately from treatment.

Stay Updated On Psychedelic News

Join our newsletter to receive updates about the latest psychedelic news, hear about our ground-breaking research, and learn what we think about the latest trends shaping the future of psychedelics.

Planning Your Psychedelic Trip?
Our Info Line Can Help.

We provide 100% free, 1:1 guidance for anyone preparing for a psychedelic experience. Learn more about our evidence-based approach or book a call today.

Learn MoreBook a Call

Pop-ups are annoying, but our emails aren't!

We hate pop-ups as much as you do, but if you want to stay up to date about the latest news in the psychedelic space and learn about our ground-breaking psychedelic research, please consider signing up for our newsletter below.